COMMUNIQUÉS West-GlobeNewswire

BEYOND IMMORTALITY: European Wellness Biomedical Group Charts Longevity Through Cell Regeneration Over Organ Transplant
30/09/2025
From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing [...]
Change in Board’s Composition
30/09/2025
Press Release Paris – September 30, 2025 - EUROAPI today announces that, in line with best governance’s practices, and following his appointment as Recipharm’s Chief Financial Officer, effective October 1 st , 2025, [...]
Evolution de la composition du Conseil d’administration
30/09/2025
Communiqué de presse Paris - Le 30 septembre 2025 - EUROAPI annonce aujourd’hui que conformément aux bonnes pratiques de gouvernance et à la suite de sa nomination en tant que directeur financier de Recipharm à compter [...]
AiM Medical Robotics Secures $8.1 Million Series A Financing to Transform Neurosurgery with MRI-Compatible Surgical Robotics
30/09/2025
— Financing round led by IQ Capital and 1540 Ventures accelerates path to first-in-human trials for groundbreaking robotic neurosurgical platform — WORCESTER, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- AiM Medical [...]
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF NOTE CONVERSION AGREEMENTS TO EXTINGUISH OVER TWO MILLION DOLLARS OF OUTSTANDING DEBT
30/09/2025
MINNEAPOLIS, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV; OTCID: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the “Company”) an emerging [...]
Total number of shares and voting rights in Zealand Pharma as of September 30, 2025
30/09/2025
Company announcement – No. 21 / 2025 Total number of shares and voting rights in Zealand Pharma as of September 30, 2025 Copenhagen, Denmark, September 30, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) ( [...]
24/7 Market News: Sportswear and Smart Textiles are likely Key Spider Silk Target Markets for Kraig Labs
30/09/2025
DENVER, Sept. 30, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, highlights the opportunity for recombinant spider [...]
PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress
30/09/2025
The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world’s leading surgical conferences PETACH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: [...]
Silexion Therapeutics Announces Positive New Human Cell Line Data Confirming Pan-KRAS Activity of SIL204, Demonstrating Up to 99.7% Inhibition and First Evidence in Gastric Cancer
30/09/2025
New data in human cancer cell lines provides confirmation of pan-KRAS mutation inhibition with inhibition of G12D, G12V, G12R, G12C, G13C, G12A, Q61H, and G13D mutations Company Reports first evidence of gastric cancer [...]
Coloplast A/S - Financial Calendar 2025-26
30/09/2025
Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://www.coloplast.com/investor-relations/events-calendar/ Kind regards, Investor Relations Coloplast A/S Tel [...]
The MUHC Foundation’s Inaugural Breakthrough Run Wins Big at the Montreal Marathon
30/09/2025
MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The MUHC Foundation proudly hosted its inaugural Breakthrough Run at the Montreal Marathon, bringing together 22 teams and almost 200 dedicated runners, including health care [...]
La première édition de la Course vers la Percée de la Fondation du CUSM remporte un franc succès lors du Marathon de Montréal
30/09/2025
MONTRÉAL, 30 sept. 2025 (GLOBE NEWSWIRE) -- La Fondation du CUSM est fière d’avoir organisé sa première Course vers la Percée lors du Marathon de Montréal. Cet événement a réuni 22 équipes et près de 200 coureurs [...]
September 2025 Letter to Shareholders
30/09/2025
VANCOUVER, Washington, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As this pivotal year continues to take shape for CytoDyn Inc. (“CytoDyn” or the “Company”), I am pleased to share the progress we have made in [...]
Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease
30/09/2025
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S. clinical trial evaluating [...]
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
30/09/2025
Previously Unpublished Data Confirms Vivos DNA Devices Offer a Safe and Effective Alternative Treatment for Children with ADHD and Obstructive Sleep Apnea LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos [...]
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
30/09/2025
Disc is seeking accelerated approval and priority review of its NDA submission FDA decision to accept and file the NDA for review occurs within 60 days of submission WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- [...]
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Ganesh Kamath as Head of Market Access
30/09/2025
Mr. Kamath brings more than 25 years of market access, pricing, and commercial operations experience to Tonix On August 15, 2025, the U.S. Food and Drug Administration approved Tonmya™ (cyclobenzaprine HCl sublingual [...]
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
30/09/2025
New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte’s Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates SAN CARLOS, Calif., Sept. 30, 2025 ( [...]
SELLAS Life Sciences Group to Host Virtual R&D Day on October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 Program Update
30/09/2025
NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for [...]

Pages